A double-blind, placebo-controlled, multicenter study to assess the safety and efficacy of dextromethorphan and quinidine at two dose levels in the treatment of the pain of diabetic neuropathy

Trial Profile

A double-blind, placebo-controlled, multicenter study to assess the safety and efficacy of dextromethorphan and quinidine at two dose levels in the treatment of the pain of diabetic neuropathy

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs Dextromethorphan/quinidine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Avanir Pharmaceuticals
  • Most Recent Events

    • 08 Feb 2012 Results published in the journal Pain Medicine, according to an Avanir Pharmaceuticals media release.
    • 20 Jun 2008 All primary endpoints met, reported in an Avanir media release (9090351).
    • 09 May 2007 Results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top